Immunocore Holdings PLC (IMCR)
32.28
+0.16
(+0.50%)
USD |
NASDAQ |
Nov 22, 16:00
32.22
-0.06
(-0.19%)
After-Hours: 20:00
Immunocore Holdings Total Assets (Quarterly): 1.085B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.085B |
| June 30, 2024 | 1.023B |
| March 31, 2024 | 993.99M |
| December 31, 2023 | 597.00M |
| September 30, 2023 | 566.27M |
| June 30, 2023 | 555.43M |
| March 31, 2023 | 533.22M |
| December 31, 2022 | 526.76M |
| September 30, 2022 | 496.56M |
| Date | Value |
|---|---|
| June 30, 2022 | 358.49M |
| March 31, 2022 | 370.48M |
| December 31, 2021 | 407.28M |
| September 30, 2021 | 444.08M |
| June 30, 2021 | 488.57M |
| March 31, 2021 | 523.89M |
| December 31, 2020 | 268.74M |
| September 30, 2020 | 168.31M |
| December 31, 2019 | 243.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
168.31M
Minimum
Sep 2020
1.085B
Maximum
Sep 2024
536.14M
Average
510.23M
Median
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 317.44M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Verona Pharma PLC | 381.82M |
| NuCana PLC | 25.38M |
| Autolus Therapeutics PLC | 827.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 706.81M |
| Shareholders Equity (Quarterly) | 377.83M |
| Debt to Equity Ratio | 1.161 |
| Current Ratio | 3.778 |
| Net Debt Paydown Yield | -5.02% |